Yu-Jen Cheng - Concepedia

Author

Yu-Jen Cheng

Kaohsiung Medical University Chung-Ho Memorial Hospital

Also Known As

Yu-Jen Cheng, Yu‐Jen CHENG, Yu‐Jen Cheng

Publications

879

Citations

H-Index

Concepts

All Affiliations

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung Medical University Chung Shan Medical University Hospital Chi Mei Medical Center Changhua Christian Hospital

About

Yu-Jen Cheng is an author at Kaohsiung Medical University Chung-Ho Memorial Hospital specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	286
2	Microbiology	6	6	155
3	Health Sciences	4	4	118
4	Cell Biology	3	3	106
5	Epidemiology	2	2	55

Yu-Jen Cheng

Publications

824

Citations

H-Index

Page 1

	Year	Citations
Associations between emotional intelligence and doctor burnout, job satisfaction and patient satisfaction Hui‐Ching Weng, Chao-Ming Hung, Yi-Tien Liu, Medical Education	2011	290
Using a Computer Kiosk to Promote Child Safety: Results of a Randomized, Controlled Trial in an Urban Pediatric Emergency Department Andrea C. Gielen, Lara B. McKenzie, Eileen M. McDonald, PEDIATRICS	2007	127
High-Mobility Group Box 1–Mediated Matrix Metalloproteinase-9 Expression in Non–Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness Po‐Len Liu, Jong‐Rung Tsai, Jhi‐Jhu Hwang, American Journal of Respiratory Cell and Molecular Biology	2009	90
Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway Yu-Jen Cheng, Jen-Wei Tsai, Kun-Chou Hsieh, Cancer Letters MedicineTumor GrowthCancer Cell BiologyBronchial NeoplasmCancer Genetics	2011	45
Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline <i>In Vitro</i> Surveillance in Taiwan Study, 2006 to 2010 Yen‐Hsu Chen, Po‐Liang Lu, Cheng-Hua Huang, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeEscherichia ColiAntibiotic ResistanceBacterial PathogensDrug Resistance	2011	43
A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species Huei-Mei Chen, Fang‐Rong Chang, Ya-Ching Hsieh, Free Radical Biology and Medicine Dna DamageOncogenic AgentMedicineApoptosisMolecular Biology	2011	39
RETRACTED: Ginkgo biloba Extract Decreases Non-Small Cell Lung Cancer Cell Migration by Downregulating Metastasis-Associated Factor Heat-Shock Protein 27 Jong‐Rung Tsai, Po‐Len Liu, Yung‐Hsiang Chen, PLoS ONE	2014	31
Agreement Assessment of Tigecycline Susceptibilities Determined by the Disk Diffusion and Broth Microdilution Methods among Commonly Encountered Resistant Bacterial Isolates: Results from the Tigecycline<i>In Vitro</i>Surveillance in Taiwan (TIST) Study, 2008 to 2010 Jien-Wei Liu, Wen‐Chien Ko, Cheng-Hua Huang, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeEscherichia ColiAntibiotic ResistanceBacterial PathogensDrug Resistance	2011	29
Trends in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Tigecycline, Daptomycin, and Linezolid and Molecular Epidemiology of the Isolates: Results from the Tigecycline <i>In Vitro</i> Surveillance in Taiwan (TIST) Study, 2006 to 2010 Hsih-Yeh Tsai, Chun‐Hsing Liao, Yen‐Hsu Chen, Antimicrobial Agents and Chemotherapy Pathogenic MicrobiologyMolecular EpidemiologySeveral ClonesTaiwanese HospitalsVancomycin-resistant Enterococcus Faecium	2012	28
The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling Yun‐Ju Chen, Yu-Jen Cheng, Amos C. Hung, Gynecologic Oncology Tumor BiologyCervical CancerMedicineSynthetic Flavonoid Wyc02-9Cancer Biology	2013	22

Page 1